Effects of Chronic Renal Failure on the Pharmacokinetics of Ruboxistaurin and its Active Metabolite 338522

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.3, 2006-01, pp. : 297-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of licochalcon A on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats

By Choi J. S. Choi J. S. Choi D. H.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 882-888

Govi-Verlag

Access to resources Recommend Favorite

Pharmacokinetics of Metrifonate and its Metabolite Dichlorvos in Healthy Volunteers and in Patients with Renal Impairment

By Heinig R.

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

By He G.

Clinical Pharmacokinetics, Vol. 37, Iss. 6, 1999-12 ,pp. : 471-484

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects

By Hossein Amini Abolhassan Ahmadiani Maryam Moazenzadeh

Clinical Drug Investigation, Vol. 24, Iss. 10, 2004-01 ,pp. : 619-623

Adis International

Access to resources Recommend Favorite

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

By Spigset Olav Hägg Staffan Stegmayr Bernd Dahlqvist Rune

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 699-703

Springer Publishing Company

Access to resources Recommend Favorite